GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

Belfast Telegraph

03 Feb 2021 0 shares 3 views

GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

Belfast Telegraph

Published 03 Feb 2021

UK-based drug maker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate on a new generation of vaccines targeting emerging variants of Covid-19.

Full Article

UK backs CureVac effort to make vaccine for COVID variants

SeattlePI.com 05 Feb 2021

LONDON (AP) —

The U.K. government says it will support a German biopharmaceutical company's effort to develop vaccines..

GSK, CureVac to make COVID-19 vaccines aimed at new variants
SeattlePI.com 03 Feb 2021
GlaxoSmithKline, CureVac to make COVID-19 vaccines aimed at new variants
CBC.ca 03 Feb 2021
Businessinsider.co.za | GSK, CureVac making 'next-generation' vaccines they say can tackle multiple Covid-19 variants at once
News24 03 Feb 2021
GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once
Business Insider 03 Feb 2021

More coverage

Plan to develop new vaccine that targets COVID-19 variants in one jab

Sky News 03 Feb 2021

Drugs giant GlaxoSmithKline and German biotech firm CureVac have struck a €150m (£130m) deal to develop next-generation COVID-19..

Plan to develop new vaccine that targets COVID-19 variants in one product

Sky News

03 Feb 2021

GSK, CureVac to make COVID vaccines targeting new variants

SeattlePI.com

03 Feb 2021

GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

You might like

Related news coverage

UK backs CureVac effort to make vaccine for COVID variants

Advertisement

More coverage

Plan to develop new vaccine that targets COVID-19 variants in one jab

Plan to develop new vaccine that targets COVID-19 variants in one product

GSK, CureVac to make COVID vaccines targeting new variants